The Pharmagellan Guide to Biotech Forecasting and Valuation Contributor(s): David, Frank S. (Author), Robey, Seth (Author), Matthews, Andrew (Author) |
|
ISBN: 099840750X ISBN-13: 9780998407500 Publisher: Pharmagellan, LLC OUR PRICE: $94.05 Product Type: Paperback Published: January 2017 |
Additional Information |
BISAC Categories: - Business & Economics | Forecasting - Business & Economics | Corporate Finance - Valuation - Business & Economics | Industries - Pharmaceutical & Biotechnology |
Physical Information: 0.32" H x 6" W x 9" (0.47 lbs) 138 pages |
Descriptions, Reviews, Etc. |
Publisher Description: If you're a biotech executive, investor, deal maker, entrepreneur, or adviser--or aspire to be one--then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies.
Whether you're making investment decisions, pitching to potential partners or funders, or assessing your own R&D program, this is the one-stop guide you need by your side. |